Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease

被引：30

作者：

Glueck, CJ ^{[1
]}

Lang, JE ^{[1
]}

Tracy, T ^{[1
]}

Sieve-Smith, L ^{[1
]}

Wang, P ^{[1
]}

机构：

[1] Jewish Hosp Cincinnati, Ctr Cholesterol, Cincinnati, OH 45229 USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1999年 / 83卷 / 10期

关键词：

D O I：

10.1016/S0002-9149(99)00130-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Thrombophilic anticardiolipin antibodies (ACLAs) are independent risk factors for atherosclerotic vascular disease, We suggest that ACLAs IgG and IgM be routinely measured as ancillary atherothrombotic risk factors in all patients with atherosclerotic vascular disease events, in those at high risk for atherosclerotic vascular disease, and in those in whom thrombosis is a major pathoetiology.

引用

页码：1490 / +

页数：6

共 20 条

[1] Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins - The atherosclerosis risk in communities (ARIC) study [J].

Folsom, AR ;

Nieto, FJ ;

McGovern, PG ;

Tsai, MY ;

Malinow, MR ;

Eckfeldt, JH ;

Hess, DL ;

Davis, CE .

CIRCULATION, 1998, 98 (03) :204-210

[2] RELATIONSHIPS BETWEEN LIPOPROTEIN(A), LIPIDS, APOLIPOPROTEINS, BASAL AND STIMULATED FIBRINOLYTIC REGULATORS, AND D-DIMER [J].

GLUECK, CJ ;

GLUECK, HI ;

TRACY, T ;

SPEIRS, J ;

MCCRAY, C ;

STROOP, D .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (02) :236-246

[3] EVIDENCE THAT HOMOCYSTEINE IS AN INDEPENDENT RISK FACTOR FOR ATHEROSCLEROSIS IN HYPERLIPIDEMIC PATIENTS [J].

GLUECK, CJ ;

SHAW, P ;

LANG, JE ;

TRACY, T ;

SIEVESMITH, L ;

WANG, Y .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (02) :132-136

[4]

GLUECK CJ, 1995, MERCK MANUAL GERIATR, P1023

[5] The pathophysiology of alveolar osteonecrosis of the jaw: Anticardiolipin antibodies, thrombophilia, and hypofibrinolysis [J].

Gruppo, R ;

Glueck, CJ ;

McMahon, RE ;

Bouquot, J ;

Rabinovich, BA ;

Becker, A ;

Tracy, T ;

Wang, P .

JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1996, 127 (05) :481-488

[6] Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids - Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein [J].

Horkko, S ;

Miller, E ;

Dudl, E ;

Reaven, P ;

Curtiss, LK ;

Zvaifler, NJ ;

Terkeltaub, R ;

Pierangeli, SS ;

Branch, DW ;

Palinski, W ;

Witztum, JL .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :815-825

[7] Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events [J].

Hughes, JR ;

Davies, JA .

THROMBOSIS RESEARCH, 1998, 89 (03) :101-106

[8] THE MANAGEMENT OF THROMBOSIS IN THE ANTIPHOSPHOLIPID-ANTIBODY SYNDROME [J].

KHAMASHTA, MA ;

CUADRADO, MJ ;

MUJIC, F ;

TAUB, NA ;

HUNT, BJ ;

HUGHES, GRV .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (15) :993-997

[9] Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in Northern Sweden [J].

Kristensen, B ;

Malm, J ;

Carlberg, B ;

Stegmayr, B ;

Backman, C ;

Fagerlund, M ;

Olsson, T .

STROKE, 1997, 28 (09) :1702-1709

[10] IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death - A prospective cohort study [J].

Levine, SR ;

SalowichPalm, L ;

Sawaya, KL ;

Perry, M ;

Spencer, HJ ;

Winkler, HJ ;

Alam, Z ;

Carey, JL .

STROKE, 1997, 28 (09) :1660-1665

← 1 2 →